HSD17B13 and metabolic dysfunction-associated steatohepatitis: They found that a loss of function, protein-truncating variant in HSD17B13 (rs72613567:TA) was associated with decreased levels of ALT and AST and lower rates of NASH, as determined by the presence of any inflammation or hepatocyte ballooning in liver histology.